F215 MTBVAC 201 Primary Immunogenicity Analysis Plan Clean.pdf (3.03 MB)

Analysis Plan

Download (3.03 MB)
presentation
posted on 29.07.2019, 06:58 by Michele Tameris, Helen Mearns, Adam Penn-Nicholson, Yolande Gregg, Nicole Bilek, Simbarashe Mabwe, Hennie Geldenhuys, Justine Shenje, Angelique Luabeya, Ingrid Murillo, Juana Doce, Nacho Aguilo, Dessislava Marinova, Eugenia Puentes, Esteban Rodríguez, Jesús Gonzalo-Asensio, Bernard Fritzell, Jelle Thole, Carlos Martin, Thomas Scriba, Mark Hatherill, MTBVAC Clinical Trial Team
Analysis plan for the primary endpoint of MTBVAC 201

History

Department/Unit

Pathology South African Tuberculosis Vaccine Initiative

Licence

Exports

Logo branding

Categories

Licence

Exports